Q4 2025 · 13F-HR
Birchview Capital, LPholdings as filed
Filed 2026-02-13 · accession 0001618205-26-000001
$170.8M
Reported value
68
Positions
2025-12-31
Period end
The Brief · Birchview Capital, LP · Q4 2025
AI · grounded in 13F
Birchview Capital, LP established a new position in LRCX valued at $6.9M. The fund also increased its holdings in PHAT by 129.4% and CMPX by 82.5%. On the sell side, the fund closed its position in AXGN, reducing its exposure by $2.1M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 482480100 | KLAC | KLA CORPORATION | $26.6M | 15.6% | 21,883 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $16.3M | 9.56% | 302,842 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $8.6M | 5.01% | 1,592,938 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $8.3M | 4.83% | 260,000 | Common | SOLE |
| 512807306 | LRCX | LAM RESEARCH CORPORATION | $6.9M | 4.04% | 40,329 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $6.7M | 3.94% | 269,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $6.3M | 3.66% | 90,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $4.8M | 2.81% | 55,000 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $4.6M | 2.67% | 171,000 | Common | SOLE |
| 69047Q102 | OVV | OVINTIV INC | $4.2M | 2.47% | 107,500 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $4.2M | 2.47% | 441,019 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $4.0M | 2.33% | 705,955 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $3.9M | 2.26% | 27,190 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $3.6M | 2.11% | 253,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $3.3M | 1.92% | 462,700 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $3.2M | 1.89% | 195,000 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $3.1M | 1.84% | 80,600 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $2.8M | 1.66% | 315,400 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $2.8M | 1.63% | 130,000 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $2.3M | 1.37% | 67,200 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $2.2M | 1.30% | 44,000 | Common | SOLE |
| 74838J101 | QDELUSD | QUIDELORTHO CORP | $2.1M | 1.21% | 72,548 | Common | SOLE |
| G6674U108 | NVCR | NOVOCURE LTD | $2.0M | 1.15% | 152,100 | Common | SOLE |
| 09075X108 | BDSX | BIODESIX INC | $2.0M | 1.14% | 286,804 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $1.9M | 1.12% | 30,000 | Common | SOLE |
| 71944F106 | PHR | PHREESIA INC | $1.9M | 1.10% | 110,700 | Common | SOLE |
| 26884L109 | EQT | EQT CORPORATION | $1.9M | 1.09% | 34,619 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $1.7M | 0.98% | 34,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $1.6M | 0.96% | 43,000 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $1.5M | 0.89% | 281,730 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $1.5M | 0.86% | 3,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $1.4M | 0.83% | 62,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.4M | 0.82% | 50,000 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $1.3M | 0.77% | 31,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $1.2M | 0.71% | 16,000 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $1.2M | 0.68% | 150,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $1.1M | 0.65% | 6,061 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $1.1M | 0.63% | 8,280 | Common | SOLE |
| 88025U109 | TXG | 10X GENOMICS INC | $962,290 | 0.56% | 59,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $941,220 | 0.55% | 21,000 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | $935,000 | 0.55% | 500,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $920,550 | 0.54% | 57,000 | Common | SOLE |
| 35671D857 | FCX | FREEPORT-MCMORAN CL-B | $916,577 | 0.54% | 18,046 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $910,468 | 0.53% | 100,827 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $828,254 | 0.48% | 29,847 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $786,960 | 0.46% | 6,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $736,781 | 0.43% | 30,789 | Common | SOLE |
| 40637H109 | HALO | HALOZYME THERAPEUTICS INC | $679,730 | 0.40% | 10,100 | Common | SOLE |
| G11196105 | — | BIOHAVEN LTD | $670,231 | 0.39% | 59,365 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $664,545 | 0.39% | 8,688 | Common | SOLE |
| 89455T109 | TMCI | TREACE MEDICAL CONCEPTS INC | $556,020 | 0.33% | 226,947 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $553,766 | 0.32% | 250,573 | Common | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $508,050 | 0.30% | 15,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $428,346 | 0.25% | 138,176 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $379,940 | 0.22% | 18,058 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MEDICAL INC | $366,967 | 0.21% | 98,913 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $351,680 | 0.21% | 14,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA TECHNOLOGIES INC | $344,900 | 0.20% | 10,000 | Common | SOLE |
| 137404109 | CADL | CANDEL THERAPEUTICS INC | $339,000 | 0.20% | 60,000 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $294,428 | 0.17% | 74,918 | Common | SOLE |
| 896442308 | TRIN | TRINITY CAP INC | $293,000 | 0.17% | 20,000 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $292,142 | 0.17% | 3,698 | Common | SOLE |
| 48662X105 | KBDC | KAYNE ANDERSON BDC INC | $286,400 | 0.17% | 20,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $207,000 | 0.12% | 20,000 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $182,193 | 0.11% | 263,018 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $97,600 | 0.06% | 10,000 | Common | SOLE |
| 256086109 | DCGO | DOCGO INC | $43,809 | 0.03% | 49,908 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $22,950 | 0.01% | 17,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.